upcoming glp 1 drugs Pharma Giants Bet on Next-Generation GLP-1 Treatments to Sustain Growth GLP Agonist Clinical Trial Pipeline

Semaglutide can: Semaglutide is available as a daily oral pill or a weekly injectable medication

adults were living with obesity in 2024, clinical guidelines began recommending GLP-1 initiation within six months of diagnosis rather than after lifestyle failure

doi: 10.1016/j.lfs.2020.118645 [DOI] [PubMed] [Google Scholar] 139

Notably, sensitivity analysis by omitting one of the studies [22] for the subgroup with treatment durations of 6 months indicated a significantly greater WL in the GLP-1RAs group compared to placebo (SMD = 0.79

doi: 10.1016/j.atherosclerosis.2015.03.026 8 LeonardiniADOriaRIncalzaMACaccioppoliCBuccheriVACignarelliAet al